Last updated 2026-08-22
- Raised $905k convertible note, Jan 2025
- Raised $3M Undisclosed Round led by D-Beta One EQ, Ltd., May 2017
- Raised debt round led by 3i L.P., Mar 2026
Total raised
$3.9M
Stage
Public
Founded
2004
Headcount
1
HQ
Tel Aviv-Yafo, Israel
Sector
Biotechnology
About
CNBX Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer. They utilize proprietary High Throughput Screening (HTS) technology and advanced bioinformatics for drug discovery. Their pipeline includes drug candidates for colorectal cancer, breast cancer, melanoma, and prostate cancer, as well as neuropsychiatric conditions.
Funding history · 4 rounds · $3.9M total
4 events/rounds · $3.9M Total Funding: $3.0M in Private Equity, $905K in Debt
Mar 2026
★ 3i L.P.
Jan 2025
May 2017
Apr 2014
★ Cannabics, Inc.
Headcount over time
1 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Show all offices (1 more)
- United States
Q&A
- What is CNBX Pharmaceuticals' primary focus?
- CNBX Pharmaceuticals is developing a platform that uses novel drug-screening tools and artificial intelligence to create cannabinoid-based cancer therapies tailored to each patient's specific profile.
- Where is CNBX Pharmaceuticals headquartered?
- CNBX Pharmaceuticals is headquartered in Tel Aviv-Yafo, Israel.
- When was CNBX Pharmaceuticals founded?
- CNBX Pharmaceuticals was founded in January 2004.
- What is the current employee count for CNBX Pharmaceuticals?
- CNBX Pharmaceuticals has 7 employees, falling within the 1-10 employee bucket.
- What is CNBX Pharmaceuticals' current market capitalization?
- CNBX Pharmaceuticals has a market capitalization of $221,585 USD.
- Under what name does CNBX Pharmaceuticals operate in Israel?
- CNBX Pharmaceuticals operates in Israel as G.R.I.N Ultra Ltd, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer.
- What is the primary sector of CNBX Pharmaceuticals?
- The primary sector for CNBX Pharmaceuticals is Health Tech & Life Sciences.
- What is the product stage of CNBX Pharmaceuticals?
- CNBX Pharmaceuticals is in the clinical trial product stage.
Team · 18
Eyal Barad
Founder · Co-Founder & CEO
Gabriel Yariv
Executive Chairman of the Board
Dr. Inbar Maymon-Pomeranchik
Independent Board Member
Dr. Gil Feiler
Head of Advisory Board
Shaul Yemal
Independent Board Member
Uri Ben-Or
CFO
Dr. Sanja Goldberg
CTO
Dr. Ilya Reznik
Head of Neuropsychiatry Development
Dr. Lior Eshdat
VP Intellectual Property
Prof. Caroline Robert
Advisory Board Member (Melanoma)
Prof. Zamir Halpern
Advisory Board Member (Gastroenterology)
Prof. Amos Toren
Advisory Board Member (Oncology)
Prof. Noam Shomron
Advisory Board Member (Big Data & AI)
Dr. Sigal Tavor
Advisory Board Member (Hematology)
Dr. Erez Scapa
Advisory Board Member
Dr. Dana Ben-Ami Shor
Advisory Board Member
Dr. Sigalit Ariely Portnoy
Advisory Board Member (Regulatory Affairs)
Dr. Tal Mofkadi
Advisory Board Member (Economics & Finance)
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2BB2C
Tags
cancermedical-cannabisoncology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cnbxpharma.com/ |
|---|---|
| linkedin.com/company/2878012 | |
| YouTube | youtube.com/channel/UCDv3HpZ8hXk3ezhKmzqx8dA |
Identifiers & details
| Legal name | CNBX Pharmaceuticals Inc. |
|---|---|
| Founded | 2004-1 |
| Employees (exact) | 1 |
| Offices | United States |
| Market cap | $222K |
| Status reason | Public on OTC on Sep, 2017; |
Radar intelligence
Web history (Wayback)
| Domain | cnbxpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515125557 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-08-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | הורביץ אלי 12 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-18 | דו~ח שנתי |